Hyperbaric research and studies for the treatment of COVID-19, an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The Outcomes of Hyperbaric Oxygen Therapy to Retrieve Hypoxemia of Severe Novel Coronavirus Pneumonia: First Case Report

Coronavirus COVID-19

Zhong Xiaoling,Tao Xiaolan,Tang Yanchao,Chen Ruiyong, HBOT Department of General Hospital of the Yangtze River Shipping, Wuhan China( Zhong Xiaoling,Tao Xiaolan); The Third District of Airforce Special Service Sanatorium, Hangzhou China(Tang Yanchao); Diving and Hyperbaric Medicine Department of Naval Medical Center, Naval Medical University, Shanghai China( Chen Ruiyong). Co-first author/Corresponding author:Chen Ruiyong,Email: Abstract: Progressive hypoxemia is the difficulty of treatment of […]

Continue reading »

COVID-19: Hypoxia, inflammation and immune response

Coronavirus

Argentina Association of Hyperbaric Medicine and Research Coronaviruses are an extensive family of viruses that can cause disease in both animals and humans. In humans, different coronaviruses cause respiratory infections that can range from the common cold to more serious illnesses such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). COVID-19 is the most recently discovered […]

Continue reading »

Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure

Coronavirus COVID-19

COMMENTARY Ahead of print publication Paul G Harch, Department of Medicine, Section of Emergency and Hyperbaric Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA Recently, two articles [1],[2] published in China featured the application of hyperbaric oxygen therapy in patients with novel coronavirus 19 (COVID-19) pneumonia. The first was a case report of a severely ill patient who was […]

Continue reading »

Demonstration report on inclusion of hyperbaric oxygen therapy in treatment of COVID-19 severe cases

Naval Specialty Medical Center Program Team Clinical reports and pathologic anatomic findings shown, progressive hypoxemia is the main cause of deterioration in patients with COVID-19.”The mortality rate of critical patients in WuHan is close to 60%, and we are trying to solve the problem of hypoxia,” Zhong Nanshan said on 27 th Feb. HBOT is the strongest non-invasive oxygen therapy. […]

Continue reading »